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Simple Summary: Tumour cell heterogeneity is the most fundamental problem in cancer diagno-
sis and therapy. Micro-diagnostic technologies able to differentiate the heterogeneous molecular,
especially metastatic, potential of single cells or cell clones already within early primary tumours
of carcinoma patients would be of utmost importance. Single molecule localisation microscopy
(SMLM) has recently allowed the imaging of subcellular features at the nanoscale. However, the
technology has mostly been limited to cultured cell lines only. We introduce a first-in-field approach
for quantitative SMLM-analysis of chromatin nanostructure in individual cells in resected, routine-
pathology colorectal carcinoma patient tissue sections, illustrating, as a first example, changes in
nuclear chromatin nanostructure and microRNA intracellular distribution within carcinoma cells as
opposed to normal cells, chromatin accessibility and microRNAs having been shown to be critical in
gene regulation and metastasis. We believe this technology to have an enormous potential for future
differential diagnosis between individual cells in the tissue context.
Abstract: Tumour cell heterogeneity, and its early individual diagnosis, is one of the most funda-
mental problems in cancer diagnosis and therapy. Single molecule localisation microscopy (SMLM)
resolves subcellular features but has been limited to cultured cell lines only. Since nuclear chromatin
architecture and microRNAs are critical in metastasis, we introduce a first-in-field approach for
quantitative SMLM-analysis of chromatin nanostructure in individual cells in resected, routine-
pathology colorectal carcinoma (CRC) patient tissue sections. Chromatin density profiles proved
to differ for cells in normal and carcinoma colorectal tissues. In tumour sections, nuclear size and
chromatin compaction percentages were significantly different in carcinoma versus normal epithelial
and other cells of colorectal tissue. SMLM analysis in nuclei from normal colorectal tissue revealed
abrupt changes in chromatin density profiles at the nanoscale, features not detected by conventional
widefield microscopy. SMLM for microRNAs relevant for metastasis was achieved in colorectal
cancer tissue at the nuclear level. Super-resolution microscopy with quantitative image evaluation
algorithms provide powerful tools to analyse chromatin nanostructure and microRNAs of individual
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cells from normal and tumour tissue at the nanoscale. Our new perspectives improve the differential
diagnosis of normal and (metastatically relevant) tumour cells at the single-cell level within the
heterogeneity of primary tumours of patients.
Keywords: chromatin density; nanoscale; tumour cell heterogeneity; microRNAs; metastasis; super-
resolution microscopy
1. Introduction
One of the most challenging problems in oncology, diagnosis and (personalised)
tumour therapy still is the huge heterogeneity of carcinoma cells within tumours of patients
with malignant diseases. It is estimated that each patient primary tumour comprises
millions of different tumour cells/tumour cell clones that differ in their molecular and
functional characteristics. Within this huge heterogeneity of cells in tumours, some cancer
cells show rather low, some others high potential to promote cancer progression, to give
rise to metastasis, which is still the cause of about 90% of cancer-related deaths [1], or to
respond, or become resistant, to classical or novel personalised therapeutic strategies [2–4].
This has been shown recently, for example, in our own whole genome sequencing work
in which it became apparent that primary tumours and their corresponding metastases
originate from a common ancestor clone each, but that metastases still develop further
changes already at the genome level as compared to their corresponding primaries, an issue
which might impact tremendously therapy response or resistance [5]. Thus, recent years
of research, especially in the fields of cancer stem cells, metastasis-initiating cells, single
cell analysis [5–8], and others have illustrated how important it will be for individualised
diagnosis and therapy to be able to differentiate cells with different molecular, metastatic,
and therapeutic potential already at the stage of the primary tumour. Especially, to improve
patient prognosis fundamentally and prospectively, it will be highly important to establish
micro-diagnostic tools able to detect, ideally, single tumour cell clones that harbour a
high risk to lead to later disease recurrence and metastasis, or particular patterns of
therapy resistance within the primary tumour, before these cells give rise to macroscopic
relapse. This would enable a new generation of targeted therapy design which is capable
of preventing crucial tumour cell clones from spreading, growing, and metastasizing.
Nuclear architecture is crucial for determining the levels of gene activation. However,
the extent and means by which chromatin structure alters gene expression are not fully
understood yet. Early detection of replication “factories” allowed for a simplified nuclear
model comprising heterochromatin (dense, inactive chromatin) and euchromatin (loose,
transcription factor-enriched chromatin) [9]. Recently, a more detailed model has been
proposed which predicts that the nuclear genome is partitioned into two co-aligned regions,
an active nuclear compartment with low DNA density and an inactive nuclear compartment
with high DNA density. There is also an interchromatin compartment in this model,
which consists of channel-like regions mostly with a very low DNA density [10]. Areas
of low density have been proposed to harbour loci of active gene transcription [10,11].
Moreover, studies have already suggested that reprogramming the chromatin status and
increasing chromatin accessibility by different molecular means in cancer cells is associated
with promoting cancer metastasis [12,13]. Moreover, the use of drugs that help recover
normal nuclear architecture features has been linked with the recovery of normal cell
phenotype [14].
Thus, diagnostic tools that involve high-resolution options within the chromatin
nanostructure might be highly interesting to identify cells critical for progression, metasta-
sis, or therapy response, if these tools could be applied directly to histopathological whole
sections already of patient primary tumours and further tissues. This would be critical also
since structural differences have been observed between cells (or cell lines) in monolayer
cultures and the same cells in tissues [15]. However, up to now, attempts in this context
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to achieve subcellular imaging of the DNA distribution in tumour cells at the nanoscale
with SMLM have been rare. In our own preliminary studies, we started to study chromatin
distribution by confocal and SMLM [16], whereby the percentage of compact chromatin
calculated from confocal microscopy images proved to differ for cells with different func-
tionality. SMLM data in nuclei from normal colorectal tissue revealed abrupt changes in
chromatin density profiles at the nanoscale, features not detected by conventional widefield
microscopy. These observations highlight the importance of advancing super-resolution
techniques like SMLM as individual diagnosis tools of single cell heterogeneity [17], as well
as the enormous potential that this can have for answering biological/medical questions
such as diagnosing individual cells within an individual patient with different metastatic
or therapy response potential.
In the diagnosis of metastatically capable cells, microRNAs (miRs) could play a highly
interesting role as well since many of these have been shown, by us and others, to be
critical players in the metastatic process [18–22]. MiRs have an average length of 22
nucleotides and belong to the class of small non-coding RNAs. They bind with their
seed sequence to the 3′ untranslated region (UTR) of their target and then degrade, or
block translation of, the target mRNA [23]. More recently, additional nuclear functions
of miRs have been elucidated, which include post-transcriptional and transcriptional
gene silencing, and the transcriptional activation of genes [24], this potentially links miR-
intracellular diagnostics to chromatin diagnostics. Specific aberrant miRNA expression
profiles have been identified in different cancer types including colorectal cancer, especially
as pro-or antagonists of metastasis at several instances. Towards this end, miR are not only
direct regulators of mRNAs for oncogenes, tumour suppressor genes, or metastatically
relevant genes, but also are able to, for example, prime metastatic niches systemically via
being spread within exosomes by primary cancer cells [25–28]. Therefore, miRNA imaging
could play an important role in cancer diagnostics but is a challenge for imaging methods
due to the short length and homologues. Several miRNA imaging methods have been
developed mainly based on in situ hybridisation (ISH) [29], nucleic acid amplification [30],
northern blotting [31], or microarray [32]. These methods have been improved with regard
to sensitivity, specificity, and imaging over the past years [33]. Nevertheless, detection
of miRNAs with microscopic methods was restricted due to the conventional limit of
resolution in optical microscopy. With the help of SMLM, we recently overcame this
limitation and showed the detection of single miRNA molecules at the superresolution
level in single cells of cultured colorectal cancer cell lines [34]. However, successfully
establishing this technology for single cell, single molecule subcellular diagnosis in specific
resected tissues of patients still remains undone.
Herein, we present the first successful combination of Fluorescence in situ Hybridisa-
tion (FISH) with SMLM based chromatin nanotexture and microRNA analysis in routine-
pathology, paraffin-embedded colorectal cancer tissue sections, to characterise cellular
heterogeneity in the primary tumour tissue of colorectal cancer patients. We believe
that this technology could be interesting for the future to identify tumour cell clones
of, for example, higher individual metastatic potential or therapy resistance, given their
chromatin texture and intracellular distribution and number of metastatically relevant
microRNA molecules.
2. Material and Methods
2.1. Ethics Approval and Colorectal Tissue Samples
Formalin-fixed, paraffin embedded (FFPE) tissue blocks were generously provided by
Prof. Alexander Marx (Pathologisches Institut, UMM/Mannheim Medical Faculty of Hei-
delberg University, Germany). Anonymous colorectal carcinoma and paired corresponding
normal (colorectal) tissue blocks were available from the archival material of the same
patients. Approval by the institutional ethics board (Ethics board II at UMM, approval
no. 2017-806R-MA) was granted to AM, waiving the need for informed consent for this
retrospective and fully anonymised analysis of archival pathological samples.
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FFPE blocks were cut using a Leica RM2255 fully automated rotary microtome. The
first few sections were discharged and 10 µm thick sections were collected on top of
previously cleaned coverslips (No. 1.5H, Paul Marienfeld, Lauda-Könishofen, Germany)
from a 37 ◦C water bath. Coverslips were transferred to a 65 ◦C oven and left there for
a minimum of 30 min. Dried slices were kept at 4 ◦C for not more than a month before
further processing (FISH, confocal microscopy or SMLM).
2.2. Fluorescence In Situ Hybridisation (FISH) on Colorectal Tissue Sections
Tissue sections on coverslips were accommodated in a custom-made Teflon coverslip
holder and placed for 5-min steps in the following solutions: Roticlear, 1:1 Roticlear: 100%
EtOH, ethanol series (100%, 95%, 70%, 50%, 25%), briefly in DI water and PBS. For the
antigen retrieval step, 2 mL of a 1 µg/mL of proteinase K (NEB, Ipswich, MA, USA)
in 50 mM Tris buffer was added per tissue section in a 6-well plate (15 min, RT, gentle
stirring). Two washes followed, one with 0.1% Tween-20/PBS and the second one with
PBS. Samples were permeabilised in a 0.5% Triton-X 100/PBS solution (1 h, RT, gentle
stirring), followed by two PBS washes and immediate dehydration in ethanol solution
steps of increasing concentration (25%, 50%, 70%, 95%, 100%), followed by air drying
(5 min each). A boundary was put around the tissue samples using Picondent Twinsil
(Picodent, Wipperfürth, Germany). Subsequent volumes were added to an extent that the
entire sample was covered (maximum 100 µL). Hybridisation solution (50% v/v formamide,
0.75 M NaCl, 75 mM Na-Citrate, 50 mg/mL heparin, 0.5% v/v Tween-20) was added to
each sample (15 min, 37 ◦C). Prior to hybridisation, miR probes were denatured at 80 ◦C for
5 min. The probes were diluted in hybridisation buffer to 200 nM and added to the samples.
Hybridisation was performed overnight at 37 ◦C. Stringent washes were performed twice
in 0.2× SSC (10 min each, RT, gentle stirring), for 5 min each at RT under gentle stirring.
2.3. DNA Probe Synthesis and Characterisation
DNA sequences complementary to the four metastatically relevant miRNAs miR-135b,
miR-210, miR-21 and miR-31 studied in this work, as well as a positive control (sequence
against U6 snRNA) and negative control (scrambled sequence) were synthesised. The
most central thymidine was exchanged for a 2′-O-propargyl-uridine (cU) (building block is
commercially available from GlenResearch) to enable the post-synthetic modification with
fluorophores via copper-catalysed azide-alkyne cycloaddition (CuAAC). The solid-phase
phosphoramidite synthesis was performed with an H6 DNA/RNA synthesizer (K&A
Laborgeräte, Schaafheim, Germany), using standard protocols. For the incorporation of
the cU-phosphoramidite, the reaction time of the coupling step was increased to 4 min.
After successful synthesis and cleavage from the solid phase with 24% ammonia solution
overnight at 60 ◦C, the synthesised DNA probes were modified in two separate sets with
Cy5-azide and AF488-azide [35]. Cy5 is a well-established fluorophore in confocal mi-
croscopy and was chosen for the proof of concept. AF488 has a better blinking behaviour
than Cy5 which makes it suitable for superresolution microscopy. After modification,
the oligonucleotides were purified via reversed-phase HPLC with a Thermo Fisher Ul-
tiMate 3000 (Thermo Fisher Scientific Inc., Waltham, MA, USA) (0–40% acetonitrile in
50 mM ammonium acetate buffer). Spectroscopic measurements were performed with
solutions of 2.5 µM FISH-probe, 2.5 µM corresponding RNA, 50 mM Na-Pi buffer, and
250 mM NaCl in water at pH 7. Absorption spectra were measured with a Varian Cary 100
UV/Vis-spectrometer, and fluorescence spectra were measured with a HORIBA FluoroMax
4 spectrofluorometer. The used excitation wavelengths were λexc = 647 nm for Cy5 probes
and λexc = 488 nm for AF488 probes.
2.4. Confocal Microscopy on Colorectal Tissue Sections
Imaging of the tissue sections was carried out on a Leica TCS SP5 STED microscope
(used in confocal mode) using either a 40×/1.1 or a 63×/1.2 water immersion objective.
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Sytox Orange was excited by using a 561 laser. A HyD detector (nm range) was employed
to capture the signals.
2.5. Chromatin Compaction Quantitative Analysis—Confocal Data
A total of 50 nuclei images of each of the colorectal cell types (normal tissue: epithelial
cells of the mucosa; stromal cells of the submucosa, and smooth muscle cells of the L. mus-
cularis layer; carcinoma: epithelial-derived tumour cells) were selected from representative
confocal images. For the analysis, the area of each nucleus was estimated using an ImageJ’s
macro. Local intensity maxima were acquired in this area. The number of detected maxima
in the nucleus was defined as the number of chromatin domains [36]. To determine the
local neighbourhood area for each peak, changes in signal intensity distribution on the
image of the stained nucleus were taken into account. All image processing was performed
by using an ImageJ algorithm [37]. To obtain the dark area of each nucleus (low chromatin
density area), the total area of all recognised domains was subtracted from the size of the
whole nucleus.
2.6. miRNA Signal Quantification and Statistical Analysis
Confocal images of samples on which FISH was performed were analysed using
Columbus Software (PerkinElmer, Waltham, MA, USA), to identify the miRNA positive
(miR+) cells within the tissue. 20×magnification fields of view from the confocal images
were analysed. A visual description of the pipeline can be found in Figure S5. Briefly,
nuclei were identified from an input image based on the nuclear dye signal intensities. A
contour was drawn estimating the cytoplasm region for each identified nucleus. Finally, a
list of cells was obtained and filtered exclusively for cells that had a strong probe signal
in the cytosolic area (defined as miR+). A strong probe signal was defined as an intensity
in the miR channel above or higher than 5. This cut-off value was chosen given that all
the measured intensities in the miR channel on negative control samples that were not
incubated with miR-probe, but scrambled sequence instead, were below this value as
background signals. Quantified values from this analysis are presented as the percentage
of miR+ cells in a given tissue area (field of view).
Statistical analysis was performed with R statistical software (version 4.0.0, The R
Foundation for Statistical Computing, Vienna, Austria). An unpaired one-sided Wilcoxon
test (p ≤ 0.05 was considered significant) was used to compare the abovementioned
quantified values between cancer tissue and its matched normal counterpart.
2.7. SMLM on Colorectal Tissue Specimen
2D single molecule localisation microscopy (SMLM) was performed on an SR GSD
setup (Leica Microsystems CMS GmbH, Wetzlar, Germany), based on an inverse widefield
microscope DMI AF6000 equipped with an oil immersion objective (160×/1.43). Fluo-
rescent emission was captured and imaged on an EMCCD camera with a pixel size of
100 nm (iXon3 Ultra 897, Andor Technology Ltd., Belfast, UK). Prior to imaging, the tissue
sections on coverslips (see colorectal tissue samples) were deparaffinised and rehydrated
(see Fluorescence in situ hybridisation on colorectal tissue sections). Samples were perme-
abilised in 0.5% Triton/PBS for 1 h, covered with 50 nM Sytox Orange in PBS for 1 h, and
embedded on freshly prepared GOX/CAT blinking buffer (0.5 mg/mL glucose oxidase
(GOX), 40 µg/mL catalase (CAT) and 10% w/v glucose, all in PBS) [16]. The coverslip was
sealed with a two-part epoxy sealant (Picondent Twinsil, Wipperfürth, Germany) to a glass
slide. All the above mentioned steps were executed at room temperature, and three PBS
washes were carried out in between steps. Samples were taken to the microscope right after
being embedded in the blinking buffer. For Sytox Orange imaging, a 561 nm laser (2.1 mW)
and 30,000 frames with 30 ms camera exposure were used. Single molecule reconstructions
were generated with ThunderSTORM (Fiji plugin).
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2.8. Quantitative Analysis (SMLM)
Chromatin Density Profiles (Binning Analysis)
To compare the chromatin density distributions between colorectal carcinoma and the
corresponding normal tissue nuclei, an in-house R script was used to bin single molecule
localisation signals in a 50 × 50 nm2 grind. The histograms were visualised in the form of
violin plots, showing the frequency of bins with a given number of localisation signals. The
R script was fed with the localisation tables obtained from ThunderSTORM (Fiji plugin,
Prague, Czech Republic). Briefly, a 2D histogram with a given bin size (50 × 50 nm2) was
generated using the geom_bin2d function. Then, the value of the number of localisations
on each bin was transferred into a table.
2.9. Radial Chromatin Density (Ring Analysis)
A region of interest (ROI) was manually drawn, enclosing the nuclear area on each of
the reconstructed images generated by ThunderSTORM. An in-house MATLAB (MATLAB
version 9.3.0 (2017b), The Mathworks, Natick, MA, USA) code was used to subdivide
the cell nucleus into six concentric rings with equal area, and to draw concentric areas
following the nuclear contour as a guide [38]. The number of localisation signals in each of
these rings served as a basis to calculate the average localisation density per ring.
3. Results
Distinctive regions within whole 10 µm tissue sections of human colorectal carcinomas
and matched corresponding normal tissues were analysed in a first-in-field attempt with
SMLM super-resolution microscopy at the nanoscale, following confocal resolution imaging.
In the following, we present results and images for chromatin density within nuclei of
carcinoma, normal epithelial, and further cell types in CRC tissue sections, followed
by single molecule microRNA subcellular analysis for selective miRs, which have been
shown to play significant roles in different aspects of metastasis [18,20,34]. Altogether, we
hypothesise that this technology could be a highly supportive tool to decipher molecular
(tumour) cell heterogeneity at the single cell level within any individual tissue context.
3.1. Chromatin Density of Nuclei from Colorectal Carcinoma and Its Corresponding
Normal Tissues
3.1.1. Chromatin Density—Confocal Resolution
Nuclei from individual tissue regions depicted in Figure S1 were analysed inde-
pendently to demonstrate that nuclei from cells with distinctive functions (benign and
malignant epithelial cells, stromal cells including smooth muscle cells from different tissue
layers) would lead to distinctive chromatin density profiles. Figure S1 shows the three
distinctive regions taken for the analysis: mucosa, submucosa, and the muscularis layer.
Nuclei analysed within the colorectal carcinoma specimen corresponded to the tumour
areas, regions enclosed in blue (Figure S1A).
To obtain a first overview of the different chromatin density distributions and features
between cell types, the human colorectal tissue nuclei were stained with Sytox Orange
and imaged with a confocal microscope (for details, see Section 2 Materials and Meth-
ods). Different nuclear architecture features were observed between (epithelial-derived)
carcinoma and normal epithelial cells, as well as between carcinoma, normal epithelial,
stromal cells within the submucosa, and smooth muscle cells within the muscularis layer.
For each of these cell types, images of 50 nuclei were selected from the confocal images for
quantitative analysis. Segmentation analysis was performed using an ImageJ algorithm
(see Section 2 Materials and Methods). The area of each nucleus was classified into either
a region of high intensity (compact chromatin) or a region of low intensity (loose chro-
matin). Figure 1 shows representative confocal images and the results after performing the
segmentation analysis. Figure 2 shows the nuclear size distributions and percentages of
chromatin compaction for the different cell types from a human colorectal carcinoma and
the corresponding normal tissue specimen.
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Figure 1. Representative confocal images of human colorectal tissue nuclei stained with Sytox Orange dye. (Ai–Ci) Images
from a normal colorectal tissue sample comprising a nucleus from the mucosa (normal epithelial cell) (Ai), the submucosa
(Bi) and the muscularis (Ci) layer. An image from a colorectal carcinoma tissue sample shows a carcinoma cell nucleus from
the tumour region (Di). Resulting images for each cell type after the segmentation analysis was performed (Aii–Dii). Scale
bars: 3 µm.
Figure 2. (Ai–Ci) Nuclear size distribution of normal colorectal tissue cell types: epithelial cells of the normal mucosa (Ai),
stromal cells (Tunica submucosa) (Bi) and muscle cells (Tunica muscularis) (Ci). Nuclear size distribution of epithelial nuclei
from a tumour area within a representative example of a colorectal carcinoma tissue specimen (Di). (Aii–Dii) Percentage of
compact chromatin in the same normal and carcinoma colorectal cell types. Solid red vertical lines correspond to the mode
from the data. Reported values are the mode ± SD. For normal distributions, the mode coincides with the mean of the
distribution. Distributions in (Cii,Dii) might correspond to a multimodal distribution (n = 50).
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To characterise and quantify the differences in chromatin density regions between
cells with different functionality (epithelial, submucosa, and muscle) and malignancy
(non-malignant epithelial versus carcinoma cells), a quantitative analysis was conducted
considering a minimum number of 50 cell nuclei from each of the abovementioned cell
types. The two main properties that were analysed were the nuclear size and the percentage
of bright nuclear area (coloured domains of Figure 1), which quantifies the chromatin
compaction.
Figure 2 shows the sizes of the nuclear cross sections in µm2 (Figure 2(Ai–Di)) as well
as the quantification of the percentage of compact chromatin per nucleus (Figure 2(Aii–Dii))
in a normal and carcinoma colorectal tissue sample with a thickness of 10 µm. Values
shown in the nuclear size distribution graphs correspond to mode values. In the case of a
normal distribution, the mode value corresponds to the mean.
Figure 2(Aii–Dii) shows the distribution of compact chromatin percentages in the
same types of cells. The vast majority of nuclei from mucosa-derived normal epithelial
and submucosal cells had a high percentage (above 90%) of their chromatin compacted
(Figure 2(Aii,Bii)). This is in agreement with a publication that showed that specialised
somatic cells have denser and more compact chromatin in comparison to, for example, stem
cells [39]. In contrast, smooth muscle cell nuclei distribution showed a higher variability
and was multimodal (two peaks), so no central value out of a population of 50 nuclei could
be reported (Figure 2(Cii)).
The same type of analysis was performed for cells from the corresponding colorectal
carcinoma tissue. Here, our attention was focused on cells belonging to a tumour area
(Figure S1). These tumour areas were delineated by an experienced pathologist depending
on the morphological changes presented by tumour cells, a common current practice in
routine pathological diagnosis. Figure 2(Di) shows the size of the nuclear cross sections in
µm2 from cells in a tumour area within a carcinoma tissue specimen. Nuclei from these
cells showed a considerably larger average nuclear size of 115 ± 51 µm2 in comparison to
their normal mucosa epithelial cell counterparts, 47 ± 16 µm2. Not only their size but also
their variability within the distribution was higher for the nuclei of carcinoma cells.
We also observed considerable differences in the distribution showing the percentages
of chromatin compaction (Figure 2(Aii, Dii)). Nuclei from carcinoma cells in the primary
tumour CRC tissue (Figure 2(Dii)) showed a broad distribution, covering cells with values
as low as 5% and as high as 96%. In contrast, nuclei from normal mucosa epithelial cells
(Figure 2(Aii)) showed a narrow distribution around a mode of 92%.
3.1.2. Chromatin Density at the Nanoscale
Colorectal tissue samples were stained with Sytox Orange, imaged, and the super-
resolution data processed as described for SMLM in Materials and Methods. Figure 3 shows
representative images of the super-resolution reconstruction images (right) alongside the
widefield images of nuclei from either carcinoma cells of the tumour region within a
colorectal carcinoma tissue (D), or from normal epithelial, submucosa-derived stromal cells,
and muscle cells of the muscle layer of corresponding normal colorectal tissue, respectively
(A–C).
The total number of blinking signals for each one of the reconstructed images shown
in Figure 3 is 0.98 × 106 (A), 0.55 × 106 (B), 1.34 × 106 (C), and 0.16 × 106 (D), respectively.
Tissue background and signals coming from neighbouring tissue nuclei were present but
did not interfere with the measurements, since the background signal within the nuclear
region was negligible. Tumour regions within cancer tissue samples still had a higher
cell density compared to the corresponding normal colorectal tissue, and therefore, the
background signals were higher and the number of blinking events lower. Therefore, to
isolate the signals coming exclusively from the nuclei of interest, regions of interest (ROIs)
were manually drawn on the widefield images, transferred to the reconstructed images,
and only localisation events within these ROIs were considered for downstream analysis.
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Figure 3. Representative SMLM images of normal colorectal cell nuclei (normal epithelial cell of normal mucosa, submucosa-
derived stromal cell, smooth muscle cell within muscular layer) within normal colorectal tissue specimen (A–C), and of
a carcinoma cell nucleus (D). Widefield images (left) and SMLM reconstructions (right) of nuclei imaged from human
colorectal tissue sections. Scale bars: 3 µm.
Figure 4 shows the chromatin density profiles of the muscle nucleus showed in
Figure 3C. Two profile lines, a vertical (red) and a horizontal (blue), were drawn in both
the widefield image (dashed lines) and the super-resolution reconstruction image (solid
lines). Figure 4B shows the intensity profiles (distance vs. intensity) for each one of the
profile lines. Intensity values correspond to the widefield image for the dashed lines, and
to the super-resolution reconstruction for the solid lines.
Figure 4. Chromatin density profiles of a normal colorectal muscle nucleus. (A) Widefield image and its super-resolved
(SMLM) reconstruction. (B) Comparison of intensity profiles taken from the widefield image (dotted lines) and the SMLM
reconstruction (solid lines). Location of active/inactive genes is hypothesised. Scale bars: 3 µm.
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Strong differences in chromatin density changes can be observed when comparing the
widefield profiles with the super-resolved ones. There is a similar trend followed by the
two profiles for each one of the graphs in Figure 4B. However, the intensity profiles from
the widefield images are not able to detect very low density chromatin regions or regions
where the chromatin is highly condensed (very strong intensity signals). The location of
active genes (in low density and hence more accessible chromatin regions) and inactive
genes (in high density chromatin regions) is hypothesised [36,40,41].
The Heterogeneity of Chromatin Density in Human Colorectal (Cancer) Tissue
Given that strong differences in the super-resolved reconstruction (SMLM) images
were observed when comparing colorectal carcinoma nuclei with the corresponding ones
of epithelial cells in normal colorectal tissue, different ways of quantifying and visually
presenting the super-resolution data are shown. Figure 5 shows the chromatin density
profile distributions for all of the different nuclei analysed. For normal colorectal tissue,
data are shown from epithelial, muscle cell and submucosa nuclei within these regions in
normal colorectal tissue (Figure 5A). Additionally, a comparison of data from carcinoma
cell nuclei (tumour region) versus normal mucosa epithelial cells are shown (Figure 5B).
Distributions from Figure 5 were obtained as described in the SMLM—Binning section
of Materials and Methods. The distributions are represented as a combination of violin
and box plots. The y-axis in Figure 5 is a logarithmic scale of the number of blinking
events (counts) in a 50 × 50 nm2 bin. The x-axis quantifies the frequency of a given count
number in a bin. It can be observed that, for all types of cells except for the mucosa-derived
normal epithelial cells, the big majority of bins had only one event. This was more strongly
observed in the carcinoma nuclei than in all of the cell types from the normal colorectal
tissue. In contrast, outlier bins (black dots in Figure 5) with very high numbers of counts
were detected in all of the different cell types measured. The horizontal black lines in the
middle of the box plots of Figure 5 represent the median for each one of the distributions.
As can be seen from the figure, the carcinoma nuclei had the lowest median value of all
(value of 3), suggesting their low density chromatin areas are more abundant than for all of
the normal colorectal cell types in all of the tissue regions investigated.
Figure 5. Violin + box plot representations of the localisation signal histograms for nuclei from different regions. A
side-by-side comparison is shown between nuclei from (A) normal epithelial cells of the mucosa, cells of the submucosa,
and of the muscularis layer, and (B) between normal epithelial cells of the normal mucosa, and carcinoma cells within
the mucosa of a tumour sample. Binning analysis was done in the super-resolved reconstruction images, and signature
chromatin density profile distributions were found for each cell type. Horizontal lines in each box plot represent the median
value of each one of the distributions. Each distribution is the combination of the replicates (7 for normal submucosa, 2 for
normal mucosa, 3 for normal muscularis and 4 for carcinoma cells in the tumour region) for each cell type. Plots of all the
replicates from each cell type can be found in Supplementary Figure S2. The horizontal black lines in the middle of the
box plots represent the median for each one of the distributions. The values are: mucosa-derived normal epithelial cells 18,
muscle cells 9, submucosal cells 13, carcinoma cells 3.
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Radial Chromatin Density
To further investigate the chromatin density differences between carcinoma cells and
normal cells, we applied the chromatin radial density analysis. The radial density analysis
allows visualizing density differences across the nucleus by measuring densities inside
rings, starting from the centre of the nucleus to the periphery of the nucleus.
Figure 6 shows the box plot representation of the chromatin radial density analysis for
nuclei taken from the epithelial, muscle cell, submucosa, and tumour regions (Figure 6A).
Additionally, a comparison of data from carcinoma cells of the tumour region versus
normal epithelial cells is shown (Figure 6B).
Figure 6. Box plot representations of the radial chromatin density analysis. Box plots show densities measured in rings
of equal area from the nuclear centre (Nucleus ring area 1) to the nuclear periphery (Nucleus ring area 6) for cells taken
from normal mucosa, normal muscularis, normal submucosa, carcinoma cells from the tumour region (A), and, for better
comparison, from epithelial cells of normal mucosa and carcinoma cells of the tumour region (B). Horizontal lines in each
box plot represent the median value of each one of the distributions.
It can be observed that the chromatin density shows a high variability across individual
nuclei and across cell types taken from different regions. For all of the cell types, chromatin
densities are highest in the outer rings, indicating a trend to higher chromatin densities
close to the nuclear periphery. The centre regions show lower chromatin densities.
Compared to the normal cells, carcinoma cell nuclei taken from the tumour region
show a pronounced variability. This becomes evident when looking at the number of out-
liers. Whereas within the normal cells, only one outlier is present for the submucosa region
in the outmost ring, the carcinoma cell distribution shows multiple outliers, suggesting an
increased variability within these cells.
3.2. miRNA Detection on Human Colon Tissue Sections
In the following, we present our work on the stepwise development of single cell, sin-
gle molecule microRNA analysis for selective, metastatically relevant miRs to be applicable
to tissue sections of human colorectal carcinomas.
3.2.1. DNA Probe Synthesis and Characterisation
After synthesis, the commercially available Cy5 dye was incorporated in all probes
of interest (as described in Materials and Methods), and the resulting probes were used
for the first step of confocal measurements. Probes with AF488 dye were used for single
molecule measurements. Figure 7 lists all the sequences of the probes, the miRNA each
one targets, and the positive and negative controls used.
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Figure 7. DNA sequences of the synthesised miRNA probes; cU = 2′-O-propargyl-uridine was modified with Cy5 (first set
of probes) and AF488 (second set of probes).
Spectroscopic measurements were performed to characterise the optical properties of
the synthetic single stranded DNA probes and as annealed hybrids with their target RNA
sequences (of the same length, Figure S3). The excitation wavelengths for the fluorescence
measurements were 647 nm for Cy5 and 488 nm for AF488, respectively, to fit the laser in
the later microscopic experiments. In all cases, the variations in UV/Vis absorption and
fluorescence of the DNA probes were rather small, showing that the optical properties
do not significantly depend on the individual sequences around the site of fluorophore
modification. The Cy5 modified probes showed a slight decrease in fluorescence due
to double strand building with the complementary miRNA targets, whereas the AF488
modified probes show a small increase of the fluorescence in the double strand except for
the miR-135b probe. The latter probe showed a small decrease that can be explained by the
hypochromic shift in absorption.
3.2.2. miRNA Signal Detection of Human Colorectal Tissues
For every set of confocal images, the background signal was subtracted (tissue with
no staining) from the images. As positive control, a U6snRNA probe was used, and a
scrambled sequence probe served as negative control (Figure S4).
miRNA probes with different fluorophores were synthesised. Amongst these, the set
of probes conjugated with Cy5 performed best since their emission spectrum is furthest
away from the tissue autofluorescence emission, which was stronger in the 488 channel.
Figure 8 shows representative confocal images of normal and carcinoma colorectal human
tissues. Images were taken in the mucosa area of each of the tissue samples. Green signals
correspond to the miRNA probes conjugated with Cy5, whereas purple signals represent
the nuclear DNA stained with Sytox Orange.
Images from Figure 8 confirmed that the four miRNAs imaged here show a higher
number of molecules in carcinoma cells of CRC cancer tissue, in contrast to a rather low or
absent expression in cells of the normal tissue. This is evident for miR-21 and especially
miR-31. For miR-135b, the signal intensity in the carcinoma tissue is lower, but still present
in comparison with miR-21 and miR-31. For miR-210, there is some miRNA signal coming
from the normal tissue in contrast to what was observed for the other miRs. Still, however,
the overall miRNA signal is higher in the carcinoma tissue.
The last column from Figure 8 offers a more detailed view of the miRNA signals. In
these zoomed images, miRNA signals appear to be located preferentially in the cytoplasm,
close to the nuclear periphery, however, other subcellular locations such as nuclear ones
cannot be excluded.
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Figure 8. Representative confocal images of FISH performed at normal and carcinoma colorectal human tissue samples with
various pro-metastatic miRNA probes: miR-21, miR-31, miR-135b, and miR-210. Green signals correspond to the Cy5 on the
miRNA probe, and purple signals represent the nuclear stain by Sytox Orange. The last column shows magnifications of the
areas delineated in white rectangles within the second last column (merged images of carcinoma tissue). The brightness
range (0–255) of images with miR signals (except the last column) was re-set to 5–100 for this figure alone to enhance the
contrast. Quantification of miRNA signals can be found in Figure 9. Scale bars: 100 µm. Scale bars for the last column:
20 µm.
miR Positive Cell Fractions
To have a better overview of the FISH results, Columbus Software (PerkinElmer) was
used to quantify the number of miR positive (miR+) cells in a given field of view (for
a description of the miR+ cells detection pipeline see Section 2 Materials and Methods
and Figure S5). miR+ cells were defined here as cells with a high miRNA probe intensity
signals located in their cytoplasm. High intensity was defined as an intensity value in the
miR channel equal to or higher than 5. Quantification analysis using Columbus Software
resulted in a list of miR+ cells with an intensity value representing how strongly a given
miRNA signal was observed in each cell’s cytoplasm region. This analysis included miRNA
negative (miR-) cells as well, which presented a probe intensity lower than 5 which was
comparable to signals detected in the background (see Section 2 Methods).
Figure 9 shows the percentage of miR+ cells according to the definition above in 20×
magnification fields of view. For each analysed field of view, the total number of cells was
quantified (as shown in Figure S5); this value represented 100%. A subset of these cells,
the miR+ cells, is shown as a percentage for each of the four miRNAs analysed: miR-21,
miR-31, miR-135b, and miR-210.
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Figure 9. Quantification of the fraction of miR+ cells in normal and colorectal carcinoma human
tissues in which FISH was done for four miRNAs that have been shown to be significant players in
metastasis. Percentage values shown are with respect to the total cell number in a 20× magnification
field of view. Unpaired one-sided Wilcoxon, * p ≤ 0.05.
For all of the four miRNAs analysed, the miR+ cell tissue fractions were always higher
in comparison to corresponding normal tissue, which matches the published literature on
these miRs including our own publications [18,20,26,34]. Differences between normal and
tumour tissues were significant in all four cases.
miRNA Signal Detection at the Nanoscale in Human Tissue Samples
Based on the previous confocal and FISH analysis, a first-in-field imaging attempt
of miRNAs was performed at the single-cell, single-molecule level in routine colorectal
cancer patient whole tissue sections. To select miR+ single cells for later SMLM, FISH with
a miR-21 probe conjugated with AF488 was conducted on a colorectal carcinoma tissue
sample. This fluorophore had to be chosen because of its blinking capabilities in pyranose
oxidase embedding buffer, with the disadvantage that its emission coincided with the
fluorescence blinking frequency in cases when colorectal tissue presented a strong level
of autofluorescence. In spite of this difficulty, SMLM images were taken successfully for
carcinoma tissue samples incubated with the miR-21 probe. MiR-signals, and vesicle-like
structures containing miR-21 signals, tended to accumulate in the periphery of the nucleus
as already shown in confocal microscopy and FISH (see above); in addition, besides some
cytoplasmic signals, they also showed localisation signals that seemed to be located inside
the nucleus (Figure 10).
Figure 10 shows the representative example of a single-cell nucleus of a human
colorectal cancer tissue sample. Figure 10A shows the conventional widefield image of the
nucleus, Figure 10B the super-resolved reconstruction image. Aggregates of considerable
size of miR-21 signals were detected in the peripheral nuclear area. MiR-21 smaller signals,
located in the cytosol, were detected as well (Figure 10B). The two small insets (white
rectangles) where miR-21 signals were found to be located in rounded shapes are enlarged
(Figure 10(Bi,Bii)). Diameters of the structures in which the miR-signal was condensed were
measured along and across (140 × 110 nm for Bi and 240 × 120 nm for Bii, respectively).
This visually confirms previous evidence that mature miRNAs, besides a well-described
localisation in the cytoplasm and within exosomes [34,42–44] are located inside the nucleus
and act, for example, like localisation signals for other biomolecules active in chromatin
restructuring, nucleolar organisation or in gene silencing/gene activation, chromatin
reorganisation in itself having been linked to an increase of metastatic capacity of tumour
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cells [13,24,45,46]. This, taken together, renders a logical link between analysing chromatin
nanostructure and miR-localisation within single cells as first attempts to tackle cancer cell
heterogeneity, including the putative metastatic potential of particular cells, within whole
tissue sections of individual patient tumours [45].
Figure 10. SMLM of miR-21 aggregates in the nuclear area of a carcinoma cell within a human colorectal cancer tissue sample.
Smaller blinking events were detected in the cytosolic area as well. (A) Widefield and (B) super-resolved reconstruction
images. Two ROIs are highlighted in white (Bi,Bii) showing miR21 aggregates. Scale bars 3 µm. Insets scale bars 200 nm.
4. Discussion
Our present study demonstrates the feasibility of our single-cell, single-molecule
localisation microscopy methodology on whole, 10 µm thick routine patient tissue sec-
tions of primary colorectal tumours and corresponding normal tissue for the diagnosis of
(changes of) chromatin texture and microRNA subcellular localisation at the nanoscale.
We have chosen changes in chromatin nanostructure and particular microRNAs as first
diagnostic targets in our attempt to transfer this technology from cell culture/monolayers
to an application in human tissue sections, since both of them have been shown to be in
the current focus of interest, and of functional importance, for the ability of tumour cells
to metastasise [12,13,18,20,34]. Metastasis, as it is well known, is still the most frequent
cause of death of cancer patients, and one of the most fundamental unsolved problems
for personalised diagnosis and therapy to date is the highly limited ability to recognise
specific, metastatically relevant cells or cell clones within the huge context of heterogeneity
in primary tumours of patients [47–49]. Ideally, diagnostic technologies are needed that
are capable of detecting metastatically relevant cells already in an individual primary tu-
mour of a patient within the first stage of initial diagnosis, before relapse and macroscopic
metastasis can arise. This also can be crucial for prospective targeted therapy planning,
which then could be specifically designed to include particular molecular changes detected
in suchlike individual cells.
In the present study, we used confocal and Single Molecule Localisation Microscopy
(SMLM) in the fBALM (fluctuation-assisted Binding-Activated Localisation Microscopy)
mode to quantitatively analyse the nuclear chromatin texture of cell nuclei in sections of
human colorectal cancer tissues. Already the confocal data (Figures 1 and 2) indicated
marked differences between the chromatin texture of nuclei in normal and tumour areas of
the tissue sections studied. This heterogeneity, however, became much more pronounced
in the super-resolved images (Figures 3–6). In this case, the local DNA density varied up
to almost two orders of magnitude and revealed a large number of very small and highly
compacted chromatin clusters down to the sub-resolution range, in apparent contrast to
the widefield images.
Very similar results were obtained previously in SMLM-fBALM studies of single nuclei
of various cell lines [16,40,50]. To our knowledge, the results reported here for the first
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time show that this unexpectedly larger heterogeneity in nuclear chromatin nanotexture
is also a prominent feature of cells of human colorectal tissue, especially of carcinoma
cells in contrast to corresponding normal epithelial cells and other cells of the colorectal
tissue context.
This large heterogeneity of nuclear chromatin distribution is typically not observed in
conventional resolution microscopy where a much smoother spatial DNA distribution is
obtained. The nanoscale heterogeneity of chromatin texture observed by SMLM-fBALM
is in striking contrast with a plethora of nuclear genome models based on sequencing
approaches like Hi-C [51,52]. These models, however, are derived from biochemical DNA–
DNA interaction probabilities; therefore, the maps constructed from these probability data
do not necessarily reflect spatial configurations. The SMLM-fBALM results presented here
show that, also in nuclei of human colorectal tissue, the spatial distribution of DNA is sub-
stantially more heterogeneous than that observed by conventional resolution microscopy:
The typically relatively smooth DNA distribution changes imaged with conventional meth-
ods were resolved by SMLM into a large number of highly compacted small chromatin
domains, interspersed within a large space of low DNA density.
These results are difficult to reconcile with the typical interaction map derived of
models cited above, but appear to be fully compatible with the basic tenets of the ANC-INC
(Active/Inactive Nuclear Compartment) model, postulating the importance of chromatin
density-related accessibility constraints for transcriptional regulation [10,36,41]. In this
model, silent gene domains are compacted to such a level of DNA density that the diffusion
of macromolecular complexes to target sequences in their interior may be restricted or even
excluded. On the other side, transcriptionally competent gene domains are characterised by
a low DNA density to enhance accessibility. Previous results obtained with SMLM-fBALM
in a mouse cardiomyocyte cell line (HL-1), using YoYo-1 as a DNA stain, also indicated
small compacted clusters (around 50–60 nm in diameter) interspersed within a large space
of low DNA density. Furthermore, transcriptionally competent small domains were almost
exclusively observed within the low density compartment only [40]. The existence of small,
highly compacted chromatin domains is also in line with previous observations obtained
by other methods of super-resolution microscopy [17,50].
Using Fluorescence in situ hybridisation (FISH) with Oligopaint probes synthesised
on the basis of sequence information, it has become possible to directly compare Hi-C data
with super-resolved microscopic observations [53]. Other recent observations also favour
the concept that nucleosomes are assembled in heterogeneous groups comprising a few
kb of DNA, termed nucleosome clutches or clusters (NCs) [39,54]. The acetylation state
determines how tightly DNA is compacted within a given NC [55]. The nucleosome cluster
concept has been supported by oligo-painting combined with super-resolved fluorescence
microscopy [56,57]. While Beliveau et al. [56] used SMLM/STORM with photoswitching
dyes, the ORCA method (Optical Reconstruction of Chromatin Architecture) applied by
Mateo et al. [57] to Drosophila embryos relied on the sequential imaging of the 3D centre
positions of the diffraction limited “spots” produced by each fluorescent probe set in the
nucleus; this allowed specific sections within a diffraction-limited volume to be resolved,
as in SMLM/STORM, while adding sequence resolution across the domain. A related
localisation approach using 3D confocal microscopy and BAC-probes for multicolour
painting has previously been reported to explore the 3D nanostructure of a specific small
chromatin breakpoint domain in human leukaemia cell nuclei [58]. A comparison of
these results with a random walk model indicated highly significant differences between
experiment and simulation.
The previous results obtained in a variety of other cell types corroborate the notion
that the high nuclear chromatin nanotexture heterogeneity observed here in human col-
orectal sections is not restricted to individual cells in monolayers but presents a general
feature of cells also in tissues. They suggest that the space-time structure of chromatin
loops in mammalian cells is generally represented by the existence of small, condensed
and dynamic nuclear domains and that these form the essential building blocks for all
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higher order chromatin structures above the nucleosome level [55]. Altogether, they argue
for a DNA density controlled accessibility of macromolecular aggregates to binding sites
in the interior of such small compacted chromatin domains. These might exhibit a highly
dynamic nanostructure, and we consider it highly likely that such dynamics will also
include, for example, significant increases in chromatin accessibility which has been ob-
served during the promotion of metastasis [13]. As a consequence, it may be hypothesised
that the accessibility conditions would change accordingly fast, in such a way that the
accessibility of a nucleosome in the ensemble centre is dynamically modified with a specific
transition frequency, depending on the mechanical elasticity parameters of the ensem-
ble [59]. These dynamics might be different, or enhanced, within the highly heterogeneous
nuclei of carcinoma cells which we have found in the present work to be substantially
different in size, nanostructure, and distribution of condensed versus relaxed chromatin
areas, as compared to corresponding normal epithelia and also other cell types within
colorectal tissue. Such a dynamic transition frequency might result in a corresponding
modification of the binding probability of transcription factors and, hence, contribute to
the fine regulation of gene expression, including genes for miRNAs, or the accessibility
for miRNAs and further regulatory molecules to modify gene transcription and chromatin
modification [24,45,46]. Since chromatin is an elastic structure, the mechanical properties
of such nucleosome clusters might contribute to affect the micro-environmental regula-
tion of genome programs [59,60]. These might include programs to promote migration,
invasion and metastasis [5], programs to interact with, and reprogram, the tumour cell
microenvironment, to increase the transcription of genes that, for example, contribute to
prime metastatic niches, to initiate programs of resistance towards particularly inflicted
therapeutic pressure, etc.
In this context, our present work also confirms, within an intact whole tissue setting,
that we found blinking signals of particular microRNAs previously discovered to be impor-
tant players in metastasis, to condense in vesicle-like shapes of the cytoplasm or also in the
nucleus. This corroborates previous SMLM super-resolution work we had presented on
microRNAs in single cells of cancer cell lines [34] and in which we had demonstrated miR-
localisation within exosomes, using an additional exosomal marker. It also corroborates
previous findings that miRs can be accumulated in exosomes which, when secreted by
tumour cells, can prime metastatic niches in distant organs via systemic spread [25,47–49].
Our first-in-field SMLM imaging of microRNAs in the nucleus of a carcinoma cell within
the whole tissue context of CRC patients also confirms the functional work of colleagues
in recent years who have discovered several nuclear functions of microRNAs in addition
to their well-studied cytoplasmic ones as translational inhibitors [24,45,46]. Towards this
end, it has been shown that microRNAs can modify, for example, gene expression (activa-
tion and silencing of transcription), chromatin remodelling and epigenetics, or nucleolar
reorganisation. This can happen via several modes of interaction such as, the binding to
nascent RNA transcripts and interactions with promoter and enhancer/silencer regions, or
acting within molecular complexes that involve Ago proteins, transcription factors, RNA
polymerase II, histone methyltransferase enzymes, and others [24]. Interestingly, one of the
interaction models currently postulated suggests that microRNAs might form triple-helical
structures with the target DNA, altering chromatin and thus accessibility for transcription
factors [24]. In this context, it is interesting to note that, a few years ago, we published a
paper showing altered triplex-DNA binding in EMSA studies of colorectal carcinoma as
compared to corresponding normal tissue nuclear extracts [61], and it remains to be studied
in the future whether carcinoma cell nuclei, in general, show higher triplex formation
phenomena as compared to normal cells, which again might be added to an arsenal of
diagnostic tools at the nanoscale to tackle single cell heterogeneity.
In summary, we have shown that SMLM super-resolution microscopy is feasible in
routine histopathological sections of carcinoma- and matched normal tissues of patients
with colorectal cancer, and we anticipate that this will be able to be extended to other
tumour types and to further molecules/molecular conditions of interest for single cell
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heterogeneity diagnosis at the nanoscale. Several future applications for this technological
approach can be anticipated, for example, the identification of single tumour cells in the
tissue context which show active particular areas of transcription, predictive features at the
nanoscale to prepare to become a cancer cell, a particular molecular potential for metastasis,
or accessibility to particular therapeutics. We envisage that technologies such as the ones we
introduce here could be advanced to automated micro-imaging devices [62], to support and
escort pathology and macro-diagnostic imaging fields for a more efficient early differential
diagnosis of heterogeneity within individual tumours and patients, up to the successful
prevention of cancer progression and metastasis. A highly intriguing additional application
of this technology might be to improve the identification and molecular differentiation of
single circulating tumour cells (CTCs) in cancer patients [63–65], after enrichment, e.g., by
flow cytometry and high content conventional resolution micros-copy. On the research side,
this would allow to test and image the hypothesis, at the single cell level, that the blood is
a pool of nucleic acids derived from different tissue sources and tumour cell subsets with
different metastatic capabilities.
5. Conclusions
We demonstrate the feasibility of our SMLM methodology on whole, 10 µm thick
patient tissue sections of carcinoma patients for the differential diagnosis of heterogeneity
in chromatin texture and microRNA subcellular localisation at the nanoscale, and anticipate
a promising potential of this methodology to detect, for example, individual carcinoma
cells with specific metastatic potential at the molecular level as early as possible in the
primary tumour context. For the future, further detailed characterisation of the chromatin
density profile and cluster analysis of the images detected with confocal microscopy and
SMLM, combined with Oligopainting of cancer-relevant DNA and RNA sequences, is
envisaged. These might allow a better understanding of the main differences of chromatin
texture, microRNA distribution, and function, in various relevant cell types, in particular,
cancer- and metastatically relevant cells. The continuous advancement of this technology,
extending to, for example, further molecules to be imaged, to the labelling of particular
genes which are active within a given chromatin location, to “multicolour” imaging of
several molecular features within the same cells and tissues, and to automated diagnostic
systems might open attractive chances to tackle intra-tumour heterogeneity at the earliest
possible diagnostic stage. This might contribute to prevent metastatic spread, design thera-
peutic strategies tailored at the individual heterogeneity of individual tumours, contribute
to the development of improved therapeutics with better targeting abilities, or predict the
accessibility of particular tumour cell fractions for essential therapeutics.
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